Has the Administrative Court’s Reversal of the IAA Decision in Pfizer Got It Right?
The issue of the relevance or not of the validity of Pfizer’s divisional patent remains, however, somewhat unanswered. Daniela Ampollini (Trevisan & Cuonzo)